Home site map Alert service English Version Who we are Pharmaceutical Business Rare diseases Investors Corporate Governance Partnering Careers Contacts Recordati is an international pharmaceutical group open to collaborations and committed to the discovery, development and sale of innovative products with high added value that improve people's quality of life. Our success benefits not only patients whose needs we want to meet, but also all those we work for - our shareholders, our customers, our scientific and commercial partners and our collaborators. Latest news Milan, 9 October 2014 Recordati: launch of the own share buyback program Lyon, 30 September 2014 ERYTECH reports positive top-line Phase III results from clinical study with GRASPA® in Acute Lymphoblastic Leukemia Other Press Releases Press releases and notices (Regulated information) Do you want to always be updated? With our Alert Service you can always be updated with the latest information. Our markets Italy France Germany Greece Ireland Portugal UK Czech Republic and Slovakia Russia and CIS Spain Turkey The Prize Arrigo Recordati To visit the site Institutional brochure To download the brochure Title Title information Annual balance To download the balance sheet To visit the site To visit the site Last update: 26/09/14 12:35:49 CET Company data Recordati SpA - VAT number: 00748210150 Privacy Terms of use Accessibility